SC 13G

Company

IGC Pharma, Inc.

Filed

February 17, 2009

Accession Number

0001019056-09-000209

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →